Value of ABO blood group in predicting the severity of children with Crimean-Congo hemorrhagic fever
- PMID: 24600498
- PMCID: PMC3931597
Value of ABO blood group in predicting the severity of children with Crimean-Congo hemorrhagic fever
Abstract
Purpose: The aim of this study was to assess the role of ABO blood groups in predicting disease severity and bleeding potential in children with Crimean-Congo hemorrhagic fever (CCHF).
Methods: One hundred fifty-one hospitalized patients with CCHF were enrolled in this retrospective study. The patients were divided according to O- and non-O- (A, B and AB) blood groups (n=91 and n=60, respectively). They were also classified into two groups (severe and non-severe) based on disease severity (n=29 and n=122, respectively). Demographic characteristics, clinical findings, and hematologic and biochemical parameters of all patients were recorded on admission and discharge.
Results: Although, in all cases, compared to the non-O blood group, the ratio of the blood group O was considerably higher (60% vs. 40%) and similarly so in severe cases (58.6% vs. 41.4%), this difference was not statistically significant (p>0.05). The aPTT at discharge and fever duration of the O-blood group were significantly higher than those of the non-O-blood group (p=0.042, p=0.034, respectively). The factor VIII level of the O-blood group was significantly lower than that of the non-O-blood group (p=0.040). Although the ratios of bleeding and severity were higher in the O-blood group compared to the other group, statistical significance was not reached (p>0.05).
Conclusions: Consideration of the ABO blood group is important during diagnostic follow-up to assess the severity of CCHF. In clinical practice, pediatric CCHF patients with the O blood group need to be followed closely for tendency to bleed.
Keywords: CCHF; bleeding; blood groups; children; disease severity.
Similar articles
-
Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever.Gene. 2019 Mar 1;687:188-192. doi: 10.1016/j.gene.2018.11.059. Epub 2018 Nov 19. Gene. 2019. PMID: 30465883
-
The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: severity prediction criteria.J Clin Virol. 2010 Apr;47(4):361-5. doi: 10.1016/j.jcv.2010.01.010. Epub 2010 Feb 9. J Clin Virol. 2010. PMID: 20149724
-
Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):441-4. doi: 10.1177/1076029612440035. Epub 2012 Mar 19. Clin Appl Thromb Hemost. 2013. PMID: 22431857
-
Prognostic factors, pathophysiology and novel biomarkers in Crimean-Congo hemorrhagic fever.Antiviral Res. 2016 Aug;132:233-43. doi: 10.1016/j.antiviral.2016.06.011. Epub 2016 Jul 1. Antiviral Res. 2016. PMID: 27378224 Review.
-
New aspects about Crimean-Congo hemorrhagic fever (CCHF) cases and associated fatality trends: A global systematic review and meta-analysis.Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101429. doi: 10.1016/j.cimid.2020.101429. Epub 2020 Feb 5. Comp Immunol Microbiol Infect Dis. 2020. PMID: 32062190
Cited by
-
Crimean-Congo Hemorrhagic Fever Case Series: a Chronology of Biochemical and Hematological Parameters.Cureus. 2022 Sep 26;14(9):e29619. doi: 10.7759/cureus.29619. eCollection 2022 Sep. Cureus. 2022. PMID: 36321017 Free PMC article.
References
-
- Whitehouse CA. Crimean-Congo hemorrhagic fever. Antivir Res. 2004;64:144–160. - PubMed
-
- Ergonul O. Crimean-Congo hemorrhagic fever virus: new outbreaks, new discoveries. Curr Opin Virol. 2012;2:215–220. - PubMed
-
- Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006;12:551–554. - PubMed
-
- Ergonul O, Celikbas A, Dokuzoguz B, Eren S, Baykam N, Esener H. The characteristics of Crimean-Congo Hemorrhagic Fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:285–289. - PubMed
-
- Greenwell P. Blood group antigens: molecules seeking a function? Glycoconj J. 1997;14:159–173. - PubMed
LinkOut - more resources
Full Text Sources